These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35617049)

  • 1. Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.
    Ionescu F; Anusim N; Zimmer M; Jaiyesimi I
    Eur J Haematol; 2022 Sep; 109(3):282-288. PubMed ID: 35617049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.
    Sakon C; Nikirk M; O'Brien ARW
    Expert Rev Hematol; 2023 Feb; 16(2):147-150. PubMed ID: 36576324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early VTE prophylaxis in severe traumatic brain injury: A propensity score weighted EAST multicenter study.
    Ratnasekera AM; Kim D; Seng SS; Jacovides C; Kaufman EJ; Sadek HM; Perea LL; Monaco C; Shnaydman I; Lee AJ; Sharp V; Miciura A; Trevizo E; Rosenthal M; Lottenberg L; Zhao W; Keininger A; Hunt M; Cull J; Balentine C; Egodage T; Mohamed A; Kincaid M; Doris S; Cotterman R; Seegert S; Jacobson LE; Williams J; Whitmill M; Palmer B; Mentzer C; Tackett N; Hranjec T; Dougherty T; Morrissey S; Donatelli-Seyler L; Rushing A; Tatebe LC; Nevill TJ; Aboutanos MB; Hamilton D; Redmond D; Cullinane DC; Falank C; McMellen M; Duran C; Daniels J; Ballow S; Schuster K; Ferrada P
    J Trauma Acute Care Surg; 2023 Jul; 95(1):94-104. PubMed ID: 37017458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease.
    Kelley D; Jones LT; Wu J; Bohm N
    J Thromb Thrombolysis; 2017 May; 43(4):463-468. PubMed ID: 27943026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of venous thromboembolism prophylaxis initiation and complications in polytrauma patients with high-risk bleeding orthopedic interventions: A nationwide analysis.
    Kobzeva-Herzog AJ; Smith SM; Counihan DR; Kain MS; Richman AP; Scantling DR; Saillant NN; Sanchez SE; Torres CM
    J Trauma Acute Care Surg; 2024 Jul; 97(1):96-104. PubMed ID: 38548689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis.
    Lovely JK; Hickman JA; Johnson MG; Naessens JM; Morgenthaler TI
    Mayo Clin Proc Innov Qual Outcomes; 2020 Apr; 4(2):159-169. PubMed ID: 32280926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of sickle hemoglobinopathies on pregnancy-related venous thromboembolism.
    Porter B; Key NS; Jauk VC; Adam S; Biggio J; Tita A
    Am J Perinatol; 2014 Oct; 31(9):805-9. PubMed ID: 24338132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When is it safe to start venous thromboembolism prophylaxis after blunt solid organ injury? A prospective American Association for the Surgery of Trauma multi-institutional trial.
    Schellenberg M; Owattanapanich N; Emigh B; Van Gent JM; Egodage T; Murphy PB; Ball CG; Spencer AL; Vogt KN; Keeley JA; Doris S; Beiling M; Donnelly M; Ghneim M; Schroeppel T; Bradford J; Breinholt CS; Coimbra R; Berndtson AE; Anding C; Charles MS; Rieger W; Inaba K;
    J Trauma Acute Care Surg; 2024 Feb; 96(2):209-215. PubMed ID: 37872669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of the Risks and Benefits of Venous Thromboembolism Prophylaxis in Traumatic Brain Injury.
    Margolick J; Dandurand C; Duncan K; Chen W; Evans DC; Sekhon MS; Garraway N; Griesdale DEG; Gooderham P; Hameed SM
    Can J Neurol Sci; 2018 Jul; 45(4):432-444. PubMed ID: 29895339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended consequences of a standard admission order set on venous thromboembolism prophylaxis and patient outcomes.
    Khanna R; Vittinghoff E; Maselli J; Auerbach A
    J Gen Intern Med; 2012 Mar; 27(3):318-24. PubMed ID: 21948203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous Thromboembolism Chemoprophylaxis Compliance in the Surgical Intensive Care Unit.
    Nichols C; Schellenberg M; Lewis MR; Emigh B; Switzer E; Inaba K
    Am Surg; 2023 Oct; 89(10):4050-4054. PubMed ID: 37183342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients.
    Davila J; Stanek J; O'Brien SH
    Blood Adv; 2023 May; 7(9):1762-1768. PubMed ID: 37103974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the incidence of hospital-associated venous thromboembolism within a network of academic hospitals: Findings from five University of California medical centers.
    Jenkins IH; White RH; Amin AN; Afsarmanesh N; Auerbach AD; Khanna R; Maynard GA
    J Hosp Med; 2016 Dec; 11 Suppl 2():S22-S28. PubMed ID: 27925421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of venous thromboprophylaxis in isolated severe pelvic fracture: Effect on mortality and outcomes.
    Benjamin E; Aiolfi A; Recinos G; Inaba K; Demetriades D
    Injury; 2019 Mar; 50(3):697-702. PubMed ID: 30797543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP; Streiff MB; Lanzkron S
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of pharmacologic venous thromboembolism prophylaxis initiation for trauma patients with nonoperatively managed blunt abdominal solid organ injury: a systematic review and meta-analysis.
    Lamb T; Lenet T; Zahrai A; Shaw JR; McLarty R; Shorr R; Le Gal G; Glen P
    World J Emerg Surg; 2022 Apr; 17(1):19. PubMed ID: 35468835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A descriptive case series of patients with end-stage liver disease hospitalized with variceal bleeding who received pharmacologic venous thromboembolism prophylaxis.
    Schleyer AM; Smith MW; Jarman KM; Crane PK; Schreuder AB; Goss JR
    J Hosp Med; 2011 Mar; 6(3):151-5. PubMed ID: 20635412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive care unit capacity strain and adherence to prophylaxis guidelines.
    Weissman GE; Gabler NB; Brown SE; Halpern SD
    J Crit Care; 2015 Dec; 30(6):1303-9. PubMed ID: 26376062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered amount and activity of superoxide dismutase in sickle cell anemia.
    Schacter L; Warth JA; Gordon EM; Prasad A; Klein BL
    FASEB J; 1988 Mar; 2(3):237-43. PubMed ID: 3350236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.